Market Performance - The pharmaceutical commercial sector increased by 0.8% on January 12, with RunDa Medical leading the gains [1] - The Shanghai Composite Index closed at 4165.29, up 1.09%, while the Shenzhen Component Index closed at 14366.91, up 1.75% [1] Top Gainers - RunDa Medical (603108) closed at 19.47, up 8.53%, with a trading volume of 1.0956 million shares and a transaction value of 2.123 billion [1] - Jia Shi Tang (002462) closed at 17.13, up 6.33%, with a trading volume of 441,200 shares and a transaction value of 733 million [1] - Yao Yi Gou (300937) closed at 38.42, up 4.54%, with a trading volume of 127,500 shares and a transaction value of 480 million [1] Top Losers - Nanjing Pharmaceutical (600713) closed at 5.43, down 1.63%, with a trading volume of 284,200 shares and a transaction value of 154 million [2] - Zhong Yao Holdings (000950) closed at 6.24, down 1.11%, with a trading volume of 740,900 shares and a transaction value of 461 million [2] - Ying Te Group (000411) closed at 12.81, down 1.08%, with a trading volume of 187,000 shares and a transaction value of 239 million [2] Capital Flow - The pharmaceutical commercial sector experienced a net outflow of 234 million from institutional investors and 184 million from speculative funds, while retail investors saw a net inflow of 417 million [2] - RunDa Medical had a net inflow of 123 million from institutional investors, but a net outflow of 171 million from speculative funds [3] - Jia Shi Tang experienced a net inflow of 80.845 million from institutional investors, with a net outflow of 28.7836 million from speculative funds [3]

Market Performance - The pharmaceutical commercial sector increased by 1.32% on January 9, with RunDa Medical leading the gains [1] - The Shanghai Composite Index closed at 4120.43, up 0.92%, while the Shenzhen Component Index closed at 14120.15, up 1.15% [1] Top Gainers - RunDa Medical (603108) closed at 17.94, up 9.99% with a trading volume of 846,200 shares [1] - Huaren Health (301408) closed at 22.17, up 9.97% with a trading volume of 627,800 shares [1] - Shangyu Pingmin (301017) closed at 17.24, up 7.75% with a trading volume of 336,500 shares [1] Other Notable Stocks - Zhongyao Holdings (000950) closed at 6.31, up 5.87% with a trading volume of 1,147,000 shares [1] - Saily Medical (603716) closed at 27.83, up 4.39% with a trading volume of 783,100 shares [1] Market Capital Flow - The pharmaceutical commercial sector experienced a net outflow of 122 million yuan from institutional investors and 174 million yuan from speculative funds, while retail investors saw a net inflow of 296 million yuan [2] - The trading volume and turnover for various stocks indicate a mixed sentiment among different investor categories [2] Individual Stock Fund Flow - RunDa Medical had a net inflow of 2.30 billion yuan from institutional investors, while it faced a net outflow of 1.36 billion yuan from speculative funds [3] - Zhongyao Holdings saw a net inflow of 61.04 million yuan from institutional investors, with a net outflow of 62.93 million yuan from retail investors [3] - The overall fund flow indicates varying levels of confidence among different investor types in the pharmaceutical sector [3]

Market Overview - The pharmaceutical commercial sector increased by 0.79% compared to the previous trading day, with Luyuan Pharmaceutical leading the gains [1] - The Shanghai Composite Index closed at 4082.98, down 0.07%, while the Shenzhen Component Index closed at 13959.48, down 0.51% [1] Top Gainers in Pharmaceutical Sector - Luyuan Pharmaceutical (002788) closed at 27.49, up 10.00% with a trading volume of 812,100 shares and a transaction value of 2.156 billion [1] - Saili Medical (603716) closed at 26.66, up 9.98% with a trading volume of 700,200 shares and a transaction value of 1.802 billion [1] - Dajia Weikang (301126) closed at 13.50, up 5.47% with a trading volume of 184,200 shares and a transaction value of 245 million [1] Other Notable Stocks - Run Da Medical (603108) closed at 16.31, up 5.23% with a trading volume of 378,400 shares and a transaction value of 614 million [1] - Huaren Health (301408) closed at 20.16, up 3.38% with a trading volume of 503,400 shares and a transaction value of 1.016 billion [1] Market Capital Flow - The pharmaceutical commercial sector experienced a net outflow of 94.4079 million from institutional investors, while retail investors saw a net inflow of 213 million [2] - The overall market showed a mixed trend with some stocks experiencing significant outflows from institutional and speculative funds [2] Individual Stock Fund Flow - Saili Medical (603716) had a net inflow of 304 million from institutional investors, but a net outflow of 108 million from speculative funds [3] - Run Da Medical (603108) saw a net inflow of 62.5499 million from institutional investors, while experiencing outflows from both speculative and retail investors [3] - Huaren Health (301408) had a net inflow of 41.8956 million from institutional investors, but a significant outflow of 64.016 million from retail investors [3]

东兴证券股份有限公司 关于漱玉平民大药房连锁股份有限公司 2025 年度现场检查报告 保荐机构名称：东兴证券股份有限公司 被保荐公司简称：漱玉平民 保荐代表人姓名：胡杰畏 联系电话：010-66555253 保荐代表人姓名：邹成凤 联系电话：010-66555253 现场检查人员姓名：胡杰畏、李晓科 现场检查对应期间：2025 年度 现场检查时间：2025 年 12 月 25 日至 12 月 26 日 一、现场检查事项 现场检查意见 （一）公司治理 是 否 不适用 现场检查手段：查阅公司章程和现行内部控制制度、治理规则等文件，检查公司三会会议文件、董 事会专业委员会文件；核查公司是否存在同业竞争和影响独立性等情形，查阅公司相关公告及定期报告 等。 1.公司章程和公司治理制度是否完备、合规 √ 2.公司章程和三会规则是否得到有效执行 √ 3.三会会议记录是否完整，时间、地点、出席人员及会议 内容等要件是否齐备，会议资料是否保存完整 √ 4.三会会议决议是否由出席会议的相关人员签名确认 √ 5.公司董监高是否按照有关法律、行政法规、部门规章、 规范性文件和本所相关业务规则履行职责 √ 6.公司董监高如发生重大变化 ...

东兴证券股份有限公司关于漱玉平民大药房连锁股份有限 本次培训得到了公司的积极配合，全体培训人员均进行了认真深入学习，通 过本次培训，被培训人员加强了关于创业板上市公司规范运作要求的认识，对相 关事项规定有了更加深刻的理解，本次培训达到了预期目标，取得了较好的效果。 公司 2025 年度持续督导现场培训报告 东兴证券股份有限公司（以下简称"保荐机构"或"东兴证券"）作为漱玉 平民大药房连锁股份有限公司（以下简称"漱玉平民"或"公司"）向不特定对 象发行可转换公司债券的保荐机构，根据《证券发行上市保荐业务管理办法》《深 圳证券交易所创业板股票上市规则》《深圳证券交易所上市公司自律监管指引第 2 号——创业板上市公司规范运作》《深圳证券交易所上市公司自律监管指引第 13 号——保荐业务》等有关规定的要求，对漱玉平民相关人员进行了 2025 年度 持续督导培训，现将培训情况报告如下： 一、本次培训基本情况 2025 年 12 月 26 日，东兴证券具体负责本次培训工作的胡杰畏先生在漱玉 平民会议室通过现场培训的方式对公司控股股东、实际控制人、部分董事和高级 管理人员、董事会办公室相关人员进行了沟通及培训。 二、本次培 ...

1、漱玉转债（债券代码：123172）转股期限为 2023 年 6 月 21 日至 2028 年 12 月 14 日，最新有效的转股价格为人民币 14.95 元/股。 2、2025 年第四季度，共有 1,180 张"漱玉转债"完成转股（票面金额共计 11.80 万元 人民币），合计转成 7,880 股"漱玉平民"股票（股票代码：301017）；截至 2025 年 12 月 31 日，合计共有 3,119 张"漱玉转债"完成转股（票面金额共计 31.19 万元人民币）， 合计转成 20,712 股"漱玉平民"股票（股票代码：301017）。 3、截至 2025 年第四季度末，漱玉平民大药房连锁股份有限公司（以下简称"公司"） 剩余可转换公司债券（以下简称"可转债"）为 7,996,881 张，剩余票面总金额为 79,968.81 万元人民币。 | | | 漱玉平民大药房连锁股份有限公司 关于 2025 年第四季度可转换公司债券转股情况的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、 误导性陈述或者重大遗漏。 特别提示： 根据《深圳证券交易所创业板股票上市规则》和《深圳证券交易所上 ...

Market Overview - The pharmaceutical commercial sector experienced a slight decline of 0.0% on December 30, with Saily Medical leading the drop [1] - The Shanghai Composite Index closed at 3965.12, also down by 0.0%, while the Shenzhen Component Index rose by 0.49% to 13604.07 [1] Stock Performance - Notable gainers in the pharmaceutical sector included: - Yingte Group (000411) with a closing price of 13.23, up by 9.98% and a trading volume of 419,800 shares [1] - Yao Yigou (300937) at 35.65, up by 7.64% with 125,700 shares traded [1] - HeFu China (603122) at 26.00, up by 6.17% with a trading volume of 985,200 shares [1] - Conversely, Saily Medical (603716) saw a decline of 3.19% to a closing price of 20.95, with a trading volume of 123,200 shares [2] Capital Flow - The pharmaceutical commercial sector saw a net inflow of 258 million yuan from institutional investors, while retail investors contributed a net inflow of 54.61 million yuan [2] - Notable capital flows included: - HeFu China (603122) with a net inflow of 286 million yuan from institutional investors [3] - Yingte Group (000411) with a net inflow of 134 million yuan from institutional investors [3] - Yao Yigou (300937) with a net inflow of 16.36 million yuan from institutional investors [3]

Group 1 - The stock of Shuyu Pingmin has dropped over 18% [1] - Other companies such as Renmin Tongtai, Dajia Weikang, Yingte Group, and Yao Yigou have all seen declines of over 5% [1] - Additional companies including Huaren Health, Zhongyao Holdings, and Kaikai Industrial have also experienced declines [1]

Group 1 - The stock of Shuyupingmin experienced a significant decline of 17.91% in a single trading day, with a turnover rate of 19.80% and a total transaction value of 767 million yuan, indicating high volatility with an amplitude of 11.33% [2] - Institutional investors net sold 69.84 million yuan worth of shares, while the Shenzhen Stock Connect saw a net purchase of 24.86 million yuan, reflecting mixed investor sentiment [2] - The top five trading departments accounted for a total transaction value of 181 million yuan, with net selling amounting to 43.44 million yuan, highlighting a trend of selling pressure from institutional investors [2] Group 2 - As of December 26, the margin trading balance for the stock was 186 million yuan, with a financing balance of 185 million yuan and a securities lending balance of 40.81 thousand yuan, indicating a substantial increase in financing activity over the past five days [3] - The financing balance increased by 51.33 million yuan, representing a growth of 38.33%, while the securities lending balance saw a minor increase of 0.82 thousand yuan, or 2.04% [3] - The trading data on December 29 showed that the top buying department was the Shenzhen Stock Connect, with a purchase amount of 25.40 million yuan, while institutional selling was concentrated among several specialized seats [3][4]

Market Overview - The pharmaceutical commercial sector experienced a decline of 1.82% on December 29, with the leading stock being Shuyupingmin [1] - The Shanghai Composite Index closed at 3965.28, up 0.04%, while the Shenzhen Component Index closed at 13537.1, down 0.49% [1] Stock Performance - Notable gainers included: - Denglushiyao (002788) with a closing price of 22.26, up 6.00% and a trading volume of 869,000 shares, totaling 1.863 billion yuan [1] - Saily Medical (603716) closed at 21.64, up 0.74% with a trading volume of 109,600 shares, totaling 237 million yuan [1] - Significant decliners included: - Shuyupingmin (301017) with a closing price of 15.58, down 17.91% and a trading volume of 481,800 shares, totaling 767 million yuan [2] - Renmintongtai (600829) closed at 11.17, down 6.84% with a trading volume of 367,700 shares, totaling 414 million yuan [2] Capital Flow - The pharmaceutical commercial sector saw a net outflow of 804 million yuan from institutional investors, while retail investors experienced a net inflow of 892 million yuan [2] - The capital flow for specific stocks showed: - Nanjing Pharmaceutical (600713) had a net inflow of 11.27 million yuan from institutional investors [3] - Shanghai Pharmaceutical (601607) saw a net inflow of 8.81 million yuan from institutional investors [3] - Dajia Weikang (301126) had a net outflow of 406,000 yuan from institutional investors [3]